General Chapter 2251 Screening for Undeclared Drugs and Drug Analogues (On-Demand)

Curriculum

Course Description:This webinar will expand the audience’s understanding of the scope and magnitude of adulteration of dietary supplements, provide methodological insight, and highlight the USP and industry resources to combat adulteration. During this webinar, an FDA scientist with extensive analytical method development experience will showcase the versatility of mass spectrometric analysis in addressing the challenges of adulterated dietary supplements screening

The live version of this course took place on May 21, 2015.Includes English subtitles. 

Access Duration:Access to this course expires 60 days from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.

Objectives:

  • Better understanding of the adulteration of dietary supplements including the regulatory, analytical, and health outcome aspects
  • A “snapshot” of the current situation: trends in illicit manufacturing, modes of adulterant concealment, crossover between adulteration categories
  • An overview of analytical methodologies suitable for DS screening: why “screening” is seen as an analytical modality of choice
  • An electronic copy of the proposed USP <2251> discussion of its structure, suggested methodologies, informational appendices, the future development of this chapter — what will the next focus area be?

 

Who should participate:

  • Analytical method developers
  • Quality control scientists
  • Analytical lab managers
  • Dietary supplement manufacturers
  • Regulatory professionals
  • Forensic scientists
  • Instrument manufacturers
  • Mass spectrometry scientists